Abstract
Discrete subaortic stenosis (DSS) is a congenital heart disease that results in the formation of a fibro-membranous tissue, causing an increased pressure gradient in the left ventricular outflow tract (LVOT). While surgical resection of the membrane has shown some success in eliminating the obstruction, it poses significant risks associated with anesthesia, sternotomy, and heart bypass, and it remains associated with a high rate of recurrence. Although a genetic etiology had been initially proposed, the association between DSS and left ventricle (LV) geometrical abnormalities has provided more support to a hemodynamic etiology by which congenital or post-surgical LVOT geometric derangements could generate abnormal shear forces on the septal wall, triggering in turn a fibrotic response. Validating this hypothetical etiology and understanding the mechanobiological processes by which altered shear forces induce fibrosis in the LVOT are major knowledge gaps. This perspective paper describes the current state of knowledge of DSS, articulates the research needs to yield mechanistic insights into a significant pathologic process that is poorly understood, and proposes several strategies aimed at elucidating the potential mechanobiological synergies responsible for DSS pathogenesis. The proposed roadmap has the potential to improve DSS management by identifying early targets for prevention of the fibrotic lesion, and may also prove beneficial in other fibrotic cardiovascular diseases associated with altered flow.
Clinical presentation
Discrete subaortic stenosis (DSS) is a congenital heart disease characterized by the formation of a fibrous membrane obstructing the left ventricular outflow tract (LVOT). DSS occurs within about 6% of children with congenital heart defects (1, 2) and is responsible for 8–30% of total LVOT obstructions in children and up to 20% of obstructions that require intervention (3, 4). Key features of the disease are its rapid progression and its association with both a high-velocity jet and a high-pressure gradient across the LVOT (5–8). The membrane that causes DSS can present with a variety of morphologies. It is most commonly described as a fibromuscular ring of tissue, but can also present as an incomplete shelf or ridge-like structure (5, 9, 10). The lesion consists of five tissue layers: (1) endothelial layer, (2) glycosaminoglycans in the sub-endothelial layer, (3) fibroelastic
layer with collagen bundles and elastin fibrils, (4) smooth muscle layer with a thickened basement membrane, and (5) fibrous layer with increased collagen (11). The location of this membrane can range from just below the aortic valve where it sometimes fuses with the leaflets, to lower within the LVOT where it can become attached to the anterior mitral valve leaflet (Figure 1) (12). Without intervention, DSS can result in left ventricle (LV) hypertrophy and dysfunction, aortic regurgitation (AR), endocarditis, arrhythmias, and death (2, 5, 13–16).
Figure 1
Different presentations of DSS showing: (A) isolated geometry; (B) involvement with the aortic valve; and (C) involvement with the mitral valve (Ao, aorta; LA, left atrium; LV, left ventricle). Adapted from (4) with permission from Elsevier.
DSS develops typically within the first decade of life and little is understood about its early development (17). The disease can present concomitantly with a variety of other congenital cardiac defects, such as bicuspid aortic valve (23% of DSS patients), ventricular septal defect (37%), and Shone's complex (4, 8, 15). Early diagnosis can be difficult as most patients remain asymptomatic throughout the disease (10, 17, 18). When present, symptoms include chest pain, heart failure, and/or syncope (8, 18). Nevertheless, DSS is usually revealed by the existence of both a mid-systolic and an end-diastolic murmur during physical examination. Diagnosis is given during a follow-up 2D Doppler echocardiography examination of the flow within the LVOT. However, cases have been reported of patients with no significant echocardiographic LVOT abnormalities in early childhood who later developed DSS at a relatively rapid rate (12, 19).
Risk factors promoting initial occurrence include morphological LVOT abnormalities such as sharp aortoseptal angle (AoSA), subphysiologic aortic annulus diameter, and large aortic valve-mitral valve separation distance (12, 16, 20, 21). Recurrence, which occurs in 8–34% of patients over a 10 year period (12, 22–27), has been associated with young age at both initial diagnosis and surgical intervention, smaller aortic annulus, proximity of the obstruction to the aortic valve, and a higher preoperative peak LVOT gradient (4, 14, 16, 25). Females have a 1.5 times greater risk of recurrence compared to males (8, 16). This increased risk could be associated with the smaller LVOT anatomies in women, but the role of gender in DSS recurrence has not been investigated (16).
Disease management
Surgical resection of the membrane alleviates the obstruction but is associated with a high rate of recurrence (12, 22–27), which has fueled the debate on timing of intervention. While some studies advocate for immediate resection to help prevent later progression and complications, others argue that resection should be considered only under certain conditions (2, 8, 12, 28). The general consensus reported in the 2008 ACC/AHA guidelines recommends surgical intervention for peak instantaneous echocardiographic gradient greater than 50 mmHg, mean gradient greater than 30 mmHg, or catheter measurement of the resting peak-to-peak gradient greater than 50 mmHg (29). Support for early intervention stems from the demonstrated success of surgery in preventing AR, especially in infants (9, 22, 24, 25, 30), while that for delayed intervention cites the potential for increased AR severity, mitral valve damage and heart block as major risks of early resection (5, 28, 30–32). Specific resection techniques range from simple removal of the membrane to a more aggressive approach combining membrane resection and myectomy (12, 17, 33). Although both effectively provide relief, the more aggressive approach has been associated with a lower instance of recurrence (25, 32) but a higher risk for iatrogenic ventricular septal defect and heart block (4, 9, 24, 26). Regardless of the surgical technique, mortality during membrane resection is reported to be approximately 3% (16, 22, 24, 34, 35).
Emergence of a hemodynamic etiology
Description
The mechanisms behind DSS pathogenesis have been subject to debate since the disease was first discovered. Initially, DSS was classified as a congenital disorder. While there are still claims that Mendelian autosomal recessive inheritance is the main mechanism behind DSS, such occurrence is rare (12, 36–38). The lack of a clear inheritance pattern along with the established association of DSS with LV morphological abnormalities has classified DSS as an acquired obstruction resulting from adverse LVOT flow patterns (12, 20, 39). This hemodynamic etiology, which hypothesizes the existence of mechanobiological synergies between the septal wall and the surrounding fluid mechanical stresses, describes DSS pathogenesis as a three-step process: (1) existent or surgically-induced LV morphological abnormalities cause (2) LV flow derangements and mechanical stress overloads on the septal wall, which trigger in turn (3) a fibrotic cellular response leading to membrane formation (9, 12, 30, 40). While this theory clearly identifies hemodynamic factors as drivers of DSS pathogenesis, it does not preclude the possible contribution of genetics in promoting a fibrotic response.
Supporting evidence
Clinical studies and case reports have used transthoracic and transesophageal echocardiography to characterize deranged flow patterns, supporting a role for hemodynamics in the pathogenesis of DSS (4, 14, 16, 25, 41, 42). Preoperative flow characteristics in DSS patients include high mean and peak LVOT gradients, marked subaortic acceleration, and transition to turbulence (42, 43). While resection results in a decrease in LVOT pressure gradient (4, 14, 16, 25), long-term follow-up assessments have evidenced a progressive linear increase in peak LVOT gradient over time (4). Regardless of its cause, an increased LVOT gradient will be associated with flow acceleration, which will translate into an increase in the interfacial force or wall shear stress (WSS) experienced by the LVOT and the subaortic region of the septal wall. These observations suggest the existence of underlying LV hemodynamic abnormalities, even in the absence of DSS lesion in those patients, which could contribute to both initial occurrence and recurrence.
While the impact of such WSS overloads on septal wall biology remains largely unknown, the knowledge gained from previous vascular mechanobiological studies offers some perspective. WSS plays a major role in cardiovascular disease through alteration of endothelial cell (EC) phenotype and loss of tissue homeostasis (44–46). In vitro studies on the effects of WSS on cardiovascular tissue and cells have demonstrated that vascular and valvular ECs interact with their surrounding mechanical environment to drive critical cell-extracellular matrix (ECM) processes. Studies have demonstrated the ability of low WSS to increase EC migration, permeability, proliferation, and activation of certain transcription factors. Regions of accelerating flow with high WSS and positive WSS spatial gradients promote ECM degradation and cellular loss, while arterial regions experiencing high WSS but negative WSS spatial gradients are protected from ECM degradation (47, 48). Those studies provide evidence for the distinct sensitivity of the vascular endothelium to WSS magnitude and spatial gradient, and the vulnerability of vascular endothelial regions subjected to elevated WSS and positive spatial gradients to inflammation, remodeling, and matrix degeneration. The sensitivity of ECs to mechanical forces combined with the histological hallmarks of DSS lesions, which include inflammation, fibrosis, and myofibroblast proliferation (12, 49, 50), suggests the activation of similar biological cascades in response to the LV flow derangements typically observed in DSS patients. More specifically, ECs subjected to WSS respond by triggering molecular pathways involving reactive oxygen species, nitric oxide, miRNAs, and growth factors (51–53). Activation of mechanosensing receptors in ECs, EC-smooth muscle cell (SMC) crosstalk, and signaling pathways in response to laminar vs. disturbed flow are rigorously investigated areas in vascular biology (52, 54–56). These processes are often mediated by PECAM-1, an EC adhesion molecule (52, 57). Vascular ECs under WSS communicate with underlying SMCs, which contribute to remodeling of the surrounding tissue and the ECM (51, 52, 54, 56). Disturbed flow is known to alter EC-SMC communication and behavior in blood vessels, but most factors in this process have yet to be characterized for endocardial ECs and their milieu (52, 55, 58).
Knowledge gap and research needs
Although the hemodynamic etiology of DSS is now relatively well accepted, its rigorous validation is still lacking. In the nearly 400 publications on DSS to date, most have focused on the echocardiographic description of LV/LVOT hemodynamics, the investigation of genetic inheritance, or the clinical and biochemical descriptions of DSS lesions. The realization that DSS pathogenesis may stem from a combination of hemodynamic and genetic cues motivates the implementation of higher-level approaches. Future research should focus on the detailed characterization of hemodynamic stresses associated with steepened AoSAs, and the elucidation of the underlying mechanobiological cellular and molecular mechanisms of DSS. Similar approaches have been successful at shedding light on the pathogenesis of calcific aortic valve disease (59–62), atherosclerosis (52, 63, 64), and bicuspid aortic valve aortopathy (65–67). The following sections present some perspective on the potential implementation of similar strategies in the context of DSS.
WSS characterization in abnormal LV anatomies
Echocardiography has evidenced the existence of global LV flow alterations in DSS patients pre- and post-resection (4, 14, 16, 25, 41, 42). Although this modality provides sufficient information for diagnostics and retrospective analysis, it is unable to capture the local flow characteristics due to its limited temporal and spatial resolutions. The elucidation of the potential synergies between the endocardial endothelium and the flow alterations associated with abnormal LV morphologies requires the implementation of more resolved approaches capable of capturing the WSS imposed by the surrounding blood flow on the septal wall. Computational and experimental techniques have been developed to quantify WSS in other cardiovascular disorders and could be implemented in the context of DSS.
Computational fluid dynamics (CFD) is a technique capable of predicting the flow characteristics at high spatial and temporal resolutions by modeling mathematically the governing equations of fluid motion. This approach consists of the creation of a three-dimensional geometry reconstructed from clinical patient images, the prescription of boundary conditions at the inlets and outlets of the model, and the numerical solution of the linearized flow equations (68). The availability of increasingly powerful workstations has enabled fluid-structure interaction (FSI) simulations that not only solve for the flow but also account for the deformation of surrounding structures and its impact on the flow (69). Such an approach is well adapted to the characterization of pulsatile flow in compliant cardiovascular structures and has been successfully implemented to capture WSS characteristics in ventricular (70–75), valvular (76–78), and aortic flows (44, 79).
Our group has recently evidenced the applicability of this computational strategy to the characterization of the hemodynamic impact of a steep AoSA in a contracting human LV reconstructed from multiple-slice cine magnetic resonance images (80). Three cases were considered: (1) normal AoSA, (2) steepened AoSA, and (3) steepened AoSA with a DSS membrane. The obstruction was represented as a thin semi-lunar membrane attached at the base of the LVOT (Figure 2A). Two-way coupling between the deforming LV and the flow was achieved in ANSYS 18 (ANSYS Inc). LV wall mechanics were modeled using an isotropic linear elastic formulation with mechanical properties representative of the average passive/active properties obtained from the literature (81, 82). LV ejection was simulated by imposing a time-dependent pressure condition on the LV wall and a wall condition on the mitral valve orifice. While the steepened AoSA generated the same LVOT flow structure as the normal AoSA, it resulted in a 6% increase in LVOT velocity at peak ejection (Figure 2B). The presence of the DSS lesion generated substantial flow alterations characterized by a recirculation bubble immediately downstream of the lesion, increased LVOT jet skewness toward the lower wall, and stenotic conditions marked by a 12% increase in maximum LVOT velocity at peak ejection. In addition, the steepened AoSA resulted in WSS abnormalities both upstream and downstream of the site prone to DSS lesion formation (24% increase in region 1, 22% decrease in region 2, vs. normal LV) (Figure 2C). These preliminary models illustrate the feasibility and benefits of CFD for the hemodynamic characterization of DSS, and suggest the existence of supra-physiologic WSS levels on the endocardial region prone to DSS lesion formation.
Figure 2
Preliminary FSI modeling in normal and DSS LVs: (A) geometrical models with normal AoSA, steepened AoSA and DSS lesion; (B) velocity predictions at early, mid-peak and peak ejection (inset: LV pressure-volume curve); and (C) WSS predictions at early, mid-peak and peak ejection.
Experimental flow techniques have also been implemented to measure LV hemodynamics in vitro. Particle image velocimetry (PIV) is a laser technique employing optical and statistical methods to measure the instantaneous velocity field in a section of the flow by capturing the average displacement of tracer particles captured in two successive flow images (83). This technique has been adapted to the characterization of the pulsatile and turbulent flow characteristics in heart valves (84–86), the aorta (87–89), and the LV (90–92). These studies typically consist of a realistic and compliant silicone model of the structure of interest connected to a flow loop generating physiologic pressure and cardiac output. PIV measurements in the LV have been performed to capture the temporal flow velocity, vorticity dynamics, and turbulence characteristics in a deforming LV (90). Although the limitations inherent to PIV prevent its use toward the capture of near-wall flow characteristics such as the regional endocardial WSS, PIV is well adapted to the assessment of bulk flow characteristics. Therefore, similar setups could be envisioned for the measurement of turbulent flow in patient-specific DSS LVs and LVOTs, which will be needed for the validation of the computational results.
Elucidation of septal wall mechanobiology
While the existence of flow derangements and WSS abnormalities in LV morphologies prone to DSS development has been partially established in vivo, their ability to trigger a fibrotic response in the endocardium also needs to be rigorously investigated. Diverse benchtop approaches allow for the application of WSS to cells, yet a major obstacle is the challenge to replicate in vitro the full spectrum of the native flow characteristics, which include three-dimensionality, pulsatility, and multidirectionality. Previous investigations of the biological response of ECs to WSS have implemented cone-and-plate bioreactors. These devices consist of an inverted cone rotating above a stationary plate supporting the cells (93). The rotation of the cone generates a flow of culture medium above the plate, resulting in the generation of WSS on the cell monolayer, making it a convenient tool for the production of a well-controlled, pulsatile/oscillatory WSS environment. The need to elucidate the role of cell-ECM communication in WSS signaling has motivated the design of more sophisticated devices capable of subjecting whole pieces of tissue to time-varying WSS (94–96). The implementation of similar devices to subject endocardial ECs or septal wall tissue to the local WSS abnormalities captured experimentally or computationally in LV morphologies prone to DSS would provide new insights into the potential transduction of altered WSS into inflammatory and fibrotic responses. In addition to the cellular response to WSS, the cellular signaling pathway and LV elastic modulus should be addressed in future studies of DSS. Resected DSS membranes show evidence of proliferation, fibrosis, and ECM remodeling (11), which provides compelling motivation to investigate the complex cell-cell communication that elicits membrane formation and fibrosis.
Complementary benchtop approaches can be employed to assess how cellular phenotype, adhesion, and migration is influenced by the stiffness of their environment (97–99). In fibrotic diseases like DSS, ECM stiffness is increased by fibrosis, which then influences cell behavior. ECs grown on stiff substrates show increased migration, proliferation, and adhesion compared with cells grown on soft substrates (99). Biomaterials can be used to mimic the elastic modulus of normal and pathological tissues so that cellular behavior in these environments can be studied (99, 100). Biomaterials can also be synthesized to present biochemical signals that influence cell behavior (99, 101). Taken together, strategies to fabricate materials in a highly customized manner (99–106) would be advantageous to use to replicate key aspects of the diverse cell communities, cell communication, and ECM microenvironments in the subaortic LVOT, such as paracrine signaling and substrate stiffness, to determine their roles in DSS.
Development of new DSS models
The current in vivo model used to study DSS is a canine animal model (11, 107–111). This model has limitations in understanding how DSS forms and the underlying mechanism of DSS. Researchers have identified an inherited genetic link associated with DSS, as shown with Newfoundland dogs (107). However, this model has not been able to identify a specific gene correlated with DSS, or if the disease is acquired or congenital (107). The presentation of DSS in dogs varies from humans so it is unclear if a canine model of DSS could clarify the mechanism of the disease (108). Therefore, a disease model that elucidates the complex physiological conditions of DSS is needed.
Development of a CFD-based surgical optimization framework
Computational engineering tools have been used as diagnosis and surgical planning tools to assess patient-specific hemodynamics in the context of Fontan and valve replacement procedures (112, 113). Similarly, CFD could be used to assess the potential benefits of resection in DSS patients. Should hemodynamics be identified as a key player in DSS lesion formation, CFD could also be implemented as a diagnosis or predictive tool for patients considered at risk for developing the disease. In both cases, the clinical implementation of CFD will require formal validation based on a combination of in vivo (e.g., PC-MRI, echocardiography) and in vitro (e.g., PIV) flow measurements.
Conclusions
DSS is a complex disorder that remains largely unexplained and difficult to treat. The risks posed by surgery along with the unpredictability of recurrence following resection justify the need to understand the underlying mechanisms of DSS. Advances in clinical imaging techniques, computational and experimental fluid dynamics, and mechanobiology provide new opportunities to elucidate the pathogenesis of this disease. The approach outlined in this paper, which suggests the use of engineering tools and clinical information in tandem, has the potential to address the molecular and cellular mechanisms of DSS, elucidate its fundamental biology, and provide new predictive capabilities that may ultimately improve patient-specific diagnosis and management. The execution of this novel strategy will require a dual expertise in both engineering and medicine, with clinicians recruiting potential patients and analyzing medical data, and engineers providing mechanical data and designing tissue culture systems.
Statements
Author contributions
DM, JS, and KB conducted the literature review and wrote the paper. JS performed and analyzed the flow simulations. PS, KG-A, and SK edited the paper and conceived the work.
Funding
This work was supported in part by the National Institutes of Health (NIH) grant R01HL140305, the National Science Foundation (NSF) grant CMMI-1550144, the American Heart Association (AHA) grant 17GRNT33350028, and the College of Engineering and Computer Science at Wright State University.
Acknowledgments
The authors would like to thank Dr. Yap Choon Hwai and Mr. Hadi Wiputra (National University of Singapore) for providing the geometry used in the LV flow simulations, and their assistance with the model. The contributions of Ms. Yao Ning and Dr. Monica Fahrenholtz are also appreciated.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1.
HoffmanJIEChristiansonR. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol. (1978) 42:641–7. 10.1016/0002-9149(78)90635-5
2.
EtnelJRGTakkenbergJJMSpaansLGBogersAJJCHelbingWA. Paediatric subvalvular aortic stenosis: a systematic review and meta-analysis of natural history and surgical outcome. Eur J Cardio-thoracic Surg. (2015) 48:212–20. 10.1093/ejcts/ezu423
3.
SadeghianHKarimiAAhmadiSHLotfi-TokaldanyMFallahNZavarRet al. Discrete subvalvular aortic stenosis: severity of aortic regurgitation and rate of recurrence at midterm follow-up after surgery. J Tehran Univ Hear Cent. (2008) 3:219–24.
4.
DonaldJSNaimoPSRichardsonMBullockAWeintraubRGBrizardCPet al. Outcomes of subaortic obstruction resection in children. Hear Lung Circ. (2017) 26:179–86. 10.1016/j.hlc.2016.05.120
5.
OzsinKKToktasFSanriUSYavuzSYavuzS. Discrete subaortic stenosis in an adult patient. Eur Res J. (2016) 2:66. 10.18621/eurj.2016.2.1.66
6.
MunHSWannLS. Noninvasive evaluation of membranous subaortic stenosis: complimentary roles of echocardiography and computed tomographic angiography. Echocardiography (2010) 27:34–6. 10.1111/j.1540-8175.2009.01075.x
7.
KriegerEV., Stout KK, Grosse-Wortmann L. How to image congenital left heart obstruction in adults. Circ Cardiovasc Imag. (2017) 10:e004271. 10.1161/CIRCIMAGING.116.004271
8.
AboulhosnJChildJS. Left ventricular outflow obstruction: subaortic stenosis, bicuspid aortic valve, supravalvar aortic stenosis, and coarctation of the aorta. Circulation (2006) 114:2412–22. 10.1161/CIRCULATIONAHA.105.592089
9.
EzonDS. Fixed subaortic stenosis: a clinical dilemma for clinicians and patients. Congenit Heart Dis. (2013) 8:450–6. 10.1111/chd.12127
10.
MarasiniMZanniniLUssiaGPPintoRMorettiRLerzoFet al. Discrete subaortic stenosis: incidence, morphology and surgical impact of associated subaortic anomalies. Ann Thorac Surg. (2003) 75:1763–8. 10.1016/S0003-4975(02)05027-0
11.
MunaWFFerransVJPierceJERobertsWC. Ultrastructure of the fibrous subaortic “ring” in dogs with discrete subaortic stenosis. Lab Investig. (1978) 39:471–82.
12.
FokerJE. Outcomes and questions about discrete subaortic stenosis. Circulation (2013) 127:1447–50. 10.1161/CIRCULATIONAHA.113.001619
13.
KleinertSGevaT. Echocardiographic morphometry and geometry of the left ventricular outflow tract in fixed subaortic stenosis. J Am Coll Cardiol. (1993) 22:1501–8. 10.1016/0735-1097(93)90563-G
14.
PickardSSGevaAGauvreauKDelNido PJGevaT. Long-term outcomes and risk factors for aortic regurgitation after discrete subvalvular aortic stenosis resection in children. Heart (2015) 101:1547–53. 10.1136/heartjnl-2015-307460
15.
SchneiderDJSinghGK. Pediatric subvalvar aortic stenosis. (2014) 6–9. Available online at: https://emedicine.medscape.com/article/893415-overview
16.
VanDer Linde DRoos-HesselinkJWRizopoulosDHeuvelmanHJBudtsWVanDijk APJet al. Surgical outcome of discrete subaortic stenosis in adults a multicenter study. Circulation (2013) 127:1184–91. 10.1161/CIRCULATIONAHA.112.000883
17.
DarcinOTYagdiTAtayYEnginCLeventEBuketSet al. Discrete subaortic stenosis: surgical outcomes and follow-up results. Tex Heart Inst J. (2003) 30:286–92.
18.
DorantesMMarreroRMéndezACastroJVázquezA. Historia familiar de muerte súbita por fibrilación ventricular idiopática. Arch Cardiol Mex. (2014) 84:57–9. 10.1016/j.acmx.2013.05.007
19.
FreedomRMFowlerRSDuncanWJ. Rapid evolution from “normal” left ventricular outflow tract to fatal subaortic stenosis in infancy. Heart (1981) 45:605–9.
20.
YapS-CRoos-HesselinkJWBogersAJJCMeijboomFJ. Steepened aortoseptal angle may be a risk factor for discrete subaortic stenosis in adults. Int J Cardiol. (2008) 126:138–9. 10.1016/j.ijcard.2007.01.078
21.
BarbozaLAGarciaF de MBarnoyaJLeon-WyssJRCastañedaAR. Subaortic Membrane and aorto-septal angle: an echocardiographic assessment and surgical outcome. World J Pediatr Congenit Hear Surg. (2013) 4:253–61. 10.1177/2150135113485760
22.
BraunerRLaksHDrinkwaterDCShvartsOEghbaliKGalindoA. Benefits of early surgical repair in fixed subaortic stenosis. J Am Coll Cardiol. (1997) 30:1835–46. 10.1016/S0735-1097(97)00410-5
23.
BrownJWRuzmetovMVijayPRodefeldMDTurrentineMW. Surgery for aortic stenosis in children: a 40-year experience. Ann Thorac Surg. (2003) 76:1398–411. 10.1016/S0003-4975(03)01027-0
24.
ErentugVBozbugaNKiraliKGoksedefDAkinciEIsikÖet al. Surgical treatment of subaortic obstruction in adolescent and adults: long-term follow-up. J Card Surg. (2005) 20:16–21. 10.1111/j.0886-0440.2005.200336.x
25.
GevaAMcMahonCJGauvreauKMohammedLdelNido PJGevaT. Risk factors for reoperation after repair of discrete subaortic stenosis in children. J Am Coll Cardiol. (2007) 50:1498–504. 10.1016/j.jacc.2007.07.013
26.
HirataYChenJMQuaegebeurJMMoscaRS. The role of enucleation with or without septal myectomy for discrete subaortic stenosis. J Thorac Cardiovasc Surg. (2009) 137:1168–72. 10.1016/j.jtcvs.2008.11.039
27.
ValeskeKHuberCMuellerMBöningAHijjehNSchranzDet al. The dilemma of subaortic stenosis–a single center experience of 15 years with a review of the literature. Thorac Cardiovasc Surg. (2011) 59:293–7. 10.1055/s-0030-1271039
28.
MaronMSOlivottoIBetocchiSCaseySALesserJRLosiMAet al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. (2003) 348:295–303. 10.1056/NEJMoa021332
29.
WarnesCAWilliamsRGBashoreTMChildJSConnollyHMDearaniJAet al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in collaboration with the american society of echocardiography, heart rhythm society, international society for adult congenital heart disease, society for cardiovascular angiography and intervention. J Am Coll Cardiol. (2008) 52:e143–263. 10.1016/j.jacc.2008.10.001
30.
OliverJMGonzálezAGallegoPSánchez-RecaldeABenitoFMesaJM. Discrete subaortic stenosis in adults: increased prevalence and slow rate of progression of the obstruction and aortic regurgitation. J Am Coll Cardiol. (2001) 38:835–42. 10.1016/S0735-1097(01)01464-4
31.
RohlicekC VdelPino SFHoskingMMiroJCôtéJMFinleyJ. Natural history and surgical outcomes for isolated discrete subaortic stenosis in children. Heart (1999) 82:708–13.
32.
OhyeRGDevaneyEJBoveEL. Resection of discrete subaortic membranes. Oper Tech Thorac Cardiovasc Surg. (2002) 7:172–5. 10.1111/jocs.13160
33.
ParryAJKovalchinJPSudaKMcElhinneyDBWudelJSilvermanNHet al. Resection of subaortic stenosis; can a more aggressive approach be justified?Eur J Cardio-thoracic Surg. (1999) 15:631–8. 10.1016/S1010-7940(99)00060-3
34.
DroletCMiroJCôtéJ-MFinleyJGardinLRohlicekC V. Long-term pediatric outcome of isolated discrete subaortic stenosis. Can J Cardiol. (2011) 27:389.e19–24. 10.1016/j.cjca.2010.12.051
35.
LupinettiFMPridjianAKCallowLBCrowleyDCBeekmanRHBoveEL. Optimum treatment of discrete subaortic stenosis. Ann Thorac Surg. (1992) 54:467–70; discussion 470–1. Available online at: http://www.ncbi.nlm.nih.gov/pubmed/1510512 (Accessed August 7, 2018)
36.
RichardsonMEMenahemSWilkinsonJL. Familial fixed subaortic stenosis. Int J Cardiol. (1991) 30:351–3.
37.
AbdallahHToomeyKO'RiordanACDavidsonAMarksLA. Pediatric cardiology 9. Pediatr Cardiol. (1994) 15:198–200.
38.
FatimiSHAhmadUJavedMAShamimSAhmadR. Familial membranous subaortic stenosis: review of familial inheritance patterns and a case report. J Thorac Cardiovasc Surg. (2006) 132:1484–7. 10.1016/j.jtcvs.2006.08.034
39.
CapeEGVanaukerMDSigfússonGTacyTAdelNido PJ. Potential role of mechanical stress in the etiology of pediatric heart disease: septal shear stress in subaortic stenosis. J Am Coll Cardiol. (1997) 30:247–54. 10.1016/S0735-1097(97)00048-X
40.
CapeEGVanaukerMDSigfússonGTacyTADelNido PJ. Potential role of mechanical stress in the etiology of pediatric heart disease: septal shear stress in subaortic stenosis. J Am Coll Cardiol. (1997) 30:247–54.
41.
AlmeidaICaetanoFTrigoJMotaPMarquesAL. High left ventricular outflow tract gradient: aortic stenosis, obstructive hypertropic cardiomyopathy or both?Rev Port Cardiol. (2015) 34:1–5. 10.1016/j.repc.2014.10.007
42.
OpotowskyARPickardSSGevaT. Imaging adult patients with discrete subvalvar aortic stenosis. Curr Opin Cardiol. (2017) 32:513–20. 10.1097/HCO.0000000000000425
43.
GewilligMDaenenWDumoulinMVanDer Hauwaert L. Rheologic genesis of discrete subvalvular aortic stenosis: a doppler echocardiographic study. J Am Coll Cardiol. (1992) 19:818–24.
44.
CaoKAtkinsSKMcNallyALiuJSucoskyP. Simulations of morphotype-dependent hemodynamics in non-dilated bicuspid aortic valve aortas. J Biomech. (2017) 50:63–70. 10.1016/j.jbiomech.2016.11.024
45.
BarkerAJLanningCShandasR. Quantification of hemodynamic wall shear stress in patients with bicuspid aortic valve using phase-contrast MRI. Ann Biomed Eng. (2010) 38:788–800. 10.1007/s10439-009-9854-3
46.
BollacheEFedakPWMVanOoij PRahmanOMalaisrieSCMccarthyPMet al. Perioperative evaluation of regional aortic wall shear stress patterns in patients undergoing aortic valve and/or proximal thoracic aortic replacement. J Thorac Cardiovasc Surg. (2017) 155:2277–86.e2. 10.1016/j.jtcvs.2017.11.007
47.
MengHWangZHoiYGaoLMetaxaESwartzDDet al. Complex hemodynamics at the apex of an arterial bifurcation induces vascular remodeling resembling cerebral aneurysm initiation. Stroke (2007) 38:1924–31. 10.1161/STROKEAHA.106.481234
48.
MetaxaETremmelMNatarajanSKXiangJPaluchRAMandelbaumMet al. Characterization of critical hemodynamics contributing to aneurysmal remodeling at the basilar terminus in a rabbit model. Stroke (2010) 41:1774–82. 10.1161/STROKEAHA.110.585992
49.
ButanyJVaideeswarPDavidTE. Discrete subaortic membranes in adults-a clinicopathological analysis. Cardiovasc Pathol. (2009) 18:236–42. 10.1016/j.carpath.2008.06.013
50.
TomasekJJGabbianiGHinzBChaponnierCBrownRA. Myofibroblasts and mechano: regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. (2002) 3:349–63. 10.1038/nrm809
51.
HsiehH-JLiuC-AHuangBTsengAHWangDL. Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications. J Biomed Sci. (2014) 21:3. 10.1186/1423-0127-21-3
52.
ChistiakovDAOrekhovANBobryshevY V. Effects of shear stress on endothelial cells: go with the flow. Acta Physiol. (2016) 219:382–408. 10.1111/apha.12725
53.
WangLHanYShenYYanZ-QZhangPYaoQ-Pet al. Endothelial insulin-like growth factor-1 modulates proliferation and phenotype of smooth muscle cells induced by low shear stress. Ann Biomed Eng. (2014) 42:776–86. 10.1007/s10439-013-0957-5
54.
HastingsNESimmersMBMcDonaldOGWamhoffBRBlackmanBR. Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am J Physiol Cell Physiol. (2007) 293:C1824–33. 10.1152/ajpcell.00385.2007
55.
ShavDGotliebRZaretskyUEladDEinavS. Wall shear stress effects on endothelial-endothelial and endothelial-smooth muscle cell interactions in tissue engineered models of the vascular wall. PLoS ONE (2014) 9:e88304. 10.1371/2Fjournal.pone.0088304
56.
SakamotoNKiuchiTSatoM. Development of an endothelial-smooth muscle cell coculture model using phenotype-controlled smooth muscle cells. Ann Biomed Eng. (2011) 39:2750–8. 10.1007/s10439-011-0372-8
57.
FlemingIFisslthalerBDixitMBusseR. Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J Cell Sci. (2005) 118:4103–11. 10.1242/jcs.02541
58.
AndoJYamamotoK. Effects of shear stress and stretch on endothelial function. Antioxid Redox Signal (2011) 15:1389–403. 10.1089/ars.2010.3361
59.
SunLRajamannanNMSucoskyP. Defining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease. PLoS ONE (2013) 8:e84433. 10.1371/journal.pone.0084433
60.
HoehnDSunLSucoskyP. Role of pathologic shear stress alterations in aortic valve endothelial activation. Cardiovasc Eng Technol. (2010) 1:165–78. 10.1007/s13239-010-0015-5
61.
SucoskyPBalachandranKElhammaliAJoHYoganathanAP. Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-beta1-dependent pathway. Arterioscler Thromb Vasc Biol. (2009) 29:254–60. 10.1161/ATVBAHA.108.176347
62.
SunLSucoskyP. Bone morphogenetic protein-4 and transforming growth factor-beta1 mechanisms in acute valvular response to supra-physiologic hemodynamic stresses. World J Cardiol. (2015) 7:331–43. 10.4330/wjc.v7.i6.331
63.
GlagovSZarinsCGiddensDPKuDN. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med. (1988) 112:1018–31.
64.
GimbroneMAGarcía-CardeñaG. Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis. Cardiovasc Pathol. (2013) 22:9–15. 10.1016/j.carpath.2012.06.006
65.
AtkinsSKSucoskyP. The etiology of bicuspid aortic valve disease: focus on hemodynamics. World J Cardiol. (2014) 12:1227–33. 10.4330/wjc.v6.i12.1227
66.
AtkinsSKMooreASucoskyP. Bicuspid aortic valve hemodynamics does not promote remodeling in porcine aortic wall concavity. World J Cardiol. (2016) 8:89–97. 10.4330/wjc.v8.i1.89
67.
AtkinsSCaoKRajamannanNMSucoskyP. Bicuspid aortic valve hemodynamics induces abnormal medial remodeling in the convexity of porcine ascending aortas. Biomech Model Mechanobiol. (2014) 13:1209–25. 10.1007/s10237-014-0567-7
68.
MittalRSeoJHVedulaVChoiYJLiuHHuangHHet al. Computational modeling of cardiac hemodynamics: current status and future outlook. J Comput Phys. (2016) 305:1065–82. 10.1016/j.jcp.2015.11.022
69.
DoneaJGuilianiSHalleuxJP. An arbitrary lagrangian-eulerian finite-element method for transient dynamic fluid structure interactions. Comput Methods Appl Mech Eng. (1982) 33:689–723. 10.1016/0045-7825(82)90128-1
70.
SuBZhongLWangX-KZhangJ-MTanRSAllenJCet al. Numerical simulation of patient-specific left ventricular model with both mitral and aortic valves by FSI approach. Comput Methods Programs Biomed. (2014) 113:474–82. 10.1016/j.cmpb.2013.11.009
71.
HoSTanGXYFooTJPhan-ThienNYapCH. Organ dynamics and fluid dynamics of the HH25 chick embryonic cardiac ventricle as revealed by a novel 4D high-frequency ultrasound imaging technique and computational flow simulations. Ann Biomed Eng. (2017) 45:2309–23. 10.1007/s10439-017-1882-9
72.
ImanparastAFatouraeeNSharifF. The impact of valve simplifications on left ventricular hemodynamics in a three dimensional simulation based on in vivo MRI data. J Biomech. (2016) 49:1482–89. 10.1016/j.jbiomech.2016.03.021
73.
SchenkelTMalveMReikMMarklMJungBOertelH. MRI-Based CFD analysis of flow in a human left ventricle: methodology and application to a healthy heart. Ann Biomed Eng. (2009) 37:503–15. 10.1007/s10439-008-9627-4
74.
McQueenDMPeskinCS. A three-dimensional computer model of the human heart for studying cardiac fluid dynamics. ACM SIGGRAPH Comput Graph. (2000) 34:56. 10.1145/563788.604453
75.
BaillargeonBRebeloNFoxDDTaylorRLKuhlE. The living heart project: a robust and integrative simulator for human heart function. Eur J Mech A/Solids (2014) 48:38–47. 10.1016/j.euromechsol.2014.04.001
76.
CaoKBukaCMSucoskyP. Three-dimensional macro-scale assessment of regional and temporal wall shear stress characteristics on aortic valve leaflets. Comput Methods Biomech Biomed Eng. (2016) 19:603–13. 10.1080/10255842.2015.1052419
77.
CaoKSucoskyP. Computational comparison of regional stress and deformation characteristics in tricuspid and bicuspid aortic valve leaflets. Int J Numer Method Biomed Eng. (2017) 33:e02798. 10.1002/cnm.2798
78.
CaoKSucoskyP. Aortic valve leaflet wall shear stress characterization revisited: impact of coronary flow. Comput Methods Biomech Biomed Eng. (2017) 20:468–70. 10.1080/10255842.2016.1244266
79.
CaoKSucoskyP. Effect of bicuspid aortic valve cusp fusion on aorta wall shear stress: preliminary computational assessment and implication for aortic dilation. World J Cardiovasc Dis. (2015) 5:129–40. 10.4236/wjcd.2015.56016
80.
VasudevanVLowAJJAnnamalaiSPSampathSPohKKTotmanTet al. Flow dynamics and energy efficiency of flow in the left ventricle during myocardial infarction. Biomech Model Mechanobiol. (2017) 16:1503–17. 10.1007/s10237-017-0902-x
81.
HunterWCJanickiJSWeberKTNoordergraafA. Systolic mechanical properties of the left ventricle. Effects of volume and contractile state. Circ Res. (1983) 52:319–27.
82.
RankinJSArentzenCERingWSEdwardsCHMcHalePAAndersonRW. The diastolic mechanical properties of the intact left ventricle. Fed Proc. (1980) 39:141–7.
83.
AdrianRJ. Particle-imaging techniques for experimental fluid mechanics. Annu Rev Fluid Mech. (1991) 23:261–304. 10.1146/annurev.fluid.23.1.261
84.
LeoHLDasiLPCarberryJSimonHAYoganathanAP. Fluid dynamic assessment of three polymeric heart valves using particle image velocimetry. Ann Biomed Eng. (2006) 34:936–52. 10.1007/s10439-006-9117-5
85.
MooreBLDasiLP. Coronary flow impacts aortic leaflet mechanics and aortic sinus hemodynamics. Ann Biomed Eng. (2015) 43:2231–41. 10.1007/s10439-015-1260-4
86.
SeamanCAkingbaAGSucoskyP. Steady flow hemodynamic and energy loss measurements in normal and simulated calcified tricuspid and bicuspid aortic valves. J Biomech Eng. (2014) 136:1–11. 10.1115/1.4026575
87.
McNallyAMadanASucoskyP. Morphotype-dependent flow characteristics in bicuspid aortic valve ascending aortas: a benchtop particle image velocimetry study. Front Physiol. (2017) 8:44. 10.3389/2Ffphys.2017.00044
88.
MooreBDasiLP. Spatiotemporal complexity of the aortic sinus vortex. Exp Fluids (2014) 55:1770. 10.1007/s00348-014-1770-0
89.
ParkHParkJHLeeSJ. In vivo measurement of hemodynamic information in stenosed rat blood vessels using X-ray PIV. Sci Rep. (2016) 6:37985. 10.1038/srep37985
90.
FalahatpishehAKheradvarA. High-speed particle image velocimetry to assess cardiac fluid dynamics in vitro: from performance to validation. Eur J Mech B/Fluids (2012) 35:2–8. 10.1016/j.euromechflu.2012.01.019
91.
BazanOOrtizJPFukumasuNKPacificoALYanagiharaJI. Influence of tricuspid bioprosthetic mitral valve orientation regarding the flow field inside the left ventricle: in vitro hydrodynamic characterization based on 2D PIV measurements. Artif Organs (2016) 40:175–9. 10.1111/aor.12515
92.
JeyhaniMShahriariSLabrosseM. Experimental investigation of left ventricular flow patterns after percutaneous edge-to-edge mitral valve repair. Artif Organs (2017) 42:516–24. 10.1111/aor.13020
93.
MooneyMEwartRH. The conicylindrical viscometer. Physics (1934) 5:350–354. 10.1063/1.1745219
94.
SucoskyPPadalaMElhammaliABalachandranKJoHYoganathanAP. Design of an ex vivo culture system to investigate the effects of shear stress on cardiovascular tissue. J Biomech Eng. (2008) 130:35001–8. 10.1115/1.2907753
95.
SunLRajamannanNMSucoskyP. Design and validation of a novel bioreactor to subject aortic valve leaflets to side-specific shear stress. Ann Biomed Eng. (2011) 39:2174–85. 10.1007/2Fs10439-011-0305-6
96.
SunLChandraSSucoskyP. Ex vivo evidence for the contribution of hemodynamic shear stress abnormalities to the early pathogenesis of calcific bicuspid aortic valve disease. PLoS ONE (2012) 7:e48843. 10.1371/journal.pone.0048843
97.
EnglerAJSenSSweeneyHLDischerDE. Matrix elasticity directs stem cell lineage specification. Cell (2006) 126:677–89. 10.1016/j.cell.2006.06.044
98.
DischerDEJanmeyPWangY-L. Tissue cells feel and respond to the stiffness of their substrate. Science (2005) 310:1139–43. 10.1126/science.1116995
99.
ChangHLiuX-QHuMZhangHLiB-CRenK-Fet al. Substrate stiffness combined with hepatocyte growth factor modulates endothelial cell behavior. Biomacromolecules (2016) 17:2767–76. 10.1021/acs.biomac.6b00318
100.
MaddenLRMortisenDJSussmanEMDuprasSKFugateJACuyJLet al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci USA. (2010) 107:15211–6. 10.1073/pnas.1006442107
101.
HuangNFLiS. Regulation of the matrix microenvironment for stem cell engineering and regenerative medicine. Ann Biomed Eng. (2011) 39:1201–14. 10.1007/2Fs10439-011-0297-2
102.
TsengHPuperiDSKimEJAyoubSShahJ VCuchiaraMLet al. Anisotropic poly(ethylene glycol)/polycaprolactone hydrogel-fiber composites for heart valve tissue engineering. Tissue Eng Part A (2014) 20:2634–45. 10.1089/ten.TEA.2013.0397
103.
PuperiDSO'ConnellRWPunskeZEWuYWestJLGrande-AllenKJ. Hyaluronan hydrogels for a biomimetic spongiosa layer of tissue engineered heart valve scaffolds. Biomacromolecules (2016) 17:1766–75. 10.1021/acs.biomac.6b00180
104.
WuYPuperiDSGrande-AllenKJWestJL. Ascorbic acid promotes extracellular matrix deposition while preserving valve interstitial cell quiescence within 3D hydrogel scaffolds. J Tissue Eng Regen Med. (2017) 11:1963–73. 10.1002/term.2093
105.
PuperiDSBalaoingLRO'ConnellRWWestJLGrande-AllenKJ. 3-Dimensional spatially organized PEG-based hydrogels for an aortic valve co-culture model. Biomaterials (2015) 67:354–64. 10.1016/j.biomaterials.2015.07.039
106.
ZhangXXuBPuperiDSYonezawaALWuYTsengHet al. Integrating valve-inspired design features into poly(ethylene glycol) hydrogel scaffolds for heart valve tissue engineering. Acta Biomater (2015) 14:11–21. 10.1016/j.actbio.2014.11.042
107.
PyleRLPattersonDFChackoS. The genetics and pathology of discrete subaortic stenosis in the Newfoundland dog. Am Heart J. (1976) 92:324–34. 10.1016/S0002-8703(76)80113-5
108.
MunaWFFerransVJPierceJERobertsWC. Discrete subaortic stenosis in Newfoundland dogs: association of infective endocarditis. Am J Cardiol. (1978) 41:746–54. 10.1016/0002-9149(78)90827-5
109.
SissonDThomasWP. Endocarditis of the aortic valve in the dog. J Am Vet Med Assoc. (1984) 184:570–7.
110.
ChetboulVTrolléJMNicolleACarlosSampedrano CGouniVLaforgeHet al. Congenital heart diseases in the boxer dog: a retrospective study of 105 cases (1998-2005). J Vet Med A Physiol Pathol Clin Med. (2006) 53:346–51. 10.1111/j.1439-0442.2006.00865.x
111.
ReedSDEvansDE. Tracheal hypoplasia with a discrete subaortic septal ridge in a Rottweiler puppy. J Vet Diagn Invest. (2009) 21:117–9. 10.1177/104063870902100118
112.
KelmMGoubergritsLBrueningJYevtushenkoPFernandesJFSündermannSHet al. Model-based therapy planning allows prediction of haemodynamic outcome after aortic valve replacement. Sci Rep. (2017) 7:9897. 10.1038/s41598-017-03693-x
113.
TrustyPMSlesnickTCWeiZARossignacJKanterKRFogelMAet al. Fontan surgical planning: previous accomplishments, current challenges, and future directions. J Cardiovasc Transl Res. (2018) 11:133–44. 10.1007/s12265-018-9786-0
Summary
Keywords
discrete subaortic stenosis, congenital heart disease, hemodynamics, etiology, left ventricular outflow tract, wall shear stress, aortoseptal angle
Citation
Massé DD, Shar JA, Brown KN, Keswani SG, Grande-Allen KJ and Sucosky P (2018) Discrete Subaortic Stenosis: Perspective Roadmap to a Complex Disease. Front. Cardiovasc. Med. 5:122. doi: 10.3389/fcvm.2018.00122
Received
20 June 2018
Accepted
17 August 2018
Published
13 September 2018
Volume
5 - 2018
Edited by
Umberto Morbiducci, Politecnico di Torino, Italy
Reviewed by
Marcus Kelm, Deutsches Herzzentrum Berlin, Germany; Fabrizio D'Ascenzo, San Giovanni Battista Molinette, Italy
Updates
Copyright
© 2018 Massé, Shar, Brown, Keswani, Grande-Allen and Sucosky.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Philippe Sucosky philippe.sucosky@wright.edu
This article was submitted to Pediatric Cardiology, a section of the journal Frontiers in Cardiovascular Medicine
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.